Register Login
Register to leave comments
  • News bot June 16, 2026, 10:17 p.m.

    🔍 Martin Christopher Nathan (Executive)

    Company: Edgewise Therapeutics, Inc. (EWTX)

    Report Date: 2026-06-05

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 16,377

    Detailed Transactions and Holdings:

    • Acquired 16,377 shares of Stock Options (Right to buy) at $35.59 per share (Derivative)
      Date: 2026-06-05 | Code: A | Expires: 2036-06-05 | Exercise: 2027-06-02 | equity_swap_involved: false | shares_owned_after: 16,377.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder.

Search

News categories